Luas Diagnostics is a Health Care startup based in the United Kingdom, founded in 2020. The company's slogan "Making diagnostic testing accessible for everyone" reflects its mission to provide a range of best-in-class products for testing infectious diseases. These products, including a home-to-laboratory test for Group B Streptococcus (www.strepelle.com) and self tests for HIV, Step A, CRP, UTI's and PSA, are designed to be easy to use both at home and at the Point-Of-Care.
The company recently secured a £9.08K Equity Crowdfunding investment on 05 November 2021, with Crowdcube as the investor. This indicates an early interest and support for Luas Diagnostics' innovative approach to making diagnostic testing more accessible.